NIH-funded research R21 grant

Cell-level changes in mitochondria after brain injury that may drive neurodegeneration

Official title: The cell-specific neurodegenerative potential of mitochondria post-traumatic brain injury

Funded at University of Cincinnati · NIH-11380805 · Data updated 2026-11-12

A new NIH grant looks at how mitochondrial problems after brain injury could set off long-term brain degeneration similar to Alzheimer’s disease.

More Brain Injury research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Cincinnati
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startAugust 1, 2024
Project endJuly 31, 2027
Funding year2026
Award (this year)$239,095
NIH project number5R21AG085052-03
Project IDNIH-11380805 on NIH RePORTER

Who could benefit from this research

Could help

Adults who have experienced traumatic brain injury or are at risk for neurodegenerative progression after TBI.

Less likely to help

The study is focused on basic mechanisms and may not offer direct benefits to every participant.

What this research studies

If this project succeeds, it could reveal how injury-related changes in cell powerhouses (mitochondria) contribute to ongoing brain inflammation and neuron loss after a traumatic brain injury. The researchers plan to study mitochondrial energy and metabolic dysfunction in specific brain cells and how that may lead to Alzheimer-like pathology over time. This could point to new biomarkers and targets for preventing long-term disability after TBI. The work combines analysis of human data with early laboratory experiments to connect acute injury to later neurodegenerative processes.

Why it matters

Potential benefit: Understanding these mechanisms could lead to new ways to prevent or slow Alzheimer-like degeneration after brain injury.

How similar studies have gone: Prior research has linked brain injury to later neurodegenerative changes, but this project aims to clarify cell-specific mitochondrial roles and pathways.

Where this research is happening

  • University of Cincinnati
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Liaudanskaya, Volha — University of Cincinnati
  • Study coordinator: Liaudanskaya, Volha

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.